Vericel Corporation has grown revenue 20% a year over three years and 15% a year over five. Revenue growth, 3-year annual rate: +20% (Biotechnology median +17%). Revenue growth, 5-year rate: +15%, growth has picked up over the last three years. Years of annual history on file: 17, FY2008 to FY2025, as filed.

VCELVericel Corporation

Healthcare

$40.12+27% 1Y

$40.12

$29.3452 weeks$47.81

Is it growing?

Excellent

Growing: revenue growing +23% year on year, earnings up +262% year on year, and operating margin widening (+6.3 points).

3 good

Revenue trend+23% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +15% a year.

Earnings trend+262% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+6.3 points operating

Trailing-twelve-month operating margin, 4.5% now against -1.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 88% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is VCEL growing?

Vericel Corporation has grown revenue 20% a year over three years and 15% a year over five.

+20%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +15%
Revenue growth, 5-year rate · +20% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2008 to FY2025, as filed

Details›